Lv1
30 积分 2022-05-06 加入
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
5个月前
已完结
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
5个月前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
5个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
6个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
6个月前
已完结
Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics
6个月前
已完结
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer
1年前
已完结
Identification of MET fusions in solid tumors: A multicenter, large scale study in China
1年前
已完结
[Expert consensus on the clinical application of antibody drug conjugates in the treatment of malignant tumors (2023 edition)]
1年前
已完结
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer
1年前
已完结
皖公网安备34019202002308
